✦ LIBER ✦

Patient-reported peripheral neuropathy of doxorubicin and cisplatin with and without paclitaxel in the treatment of advanced endometrial cancer: Results from GOG 184

✍ Scribed by David Cella; Helen Huang; Howard D. Homesley; Anthony Montag; Ritu Salani; Koen De Geest; Roger Lee; Nick M. Spirtos

Book ID: 113962607
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 260 KB
Volume: 119
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2010.08.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised trial comparing combinations

Randomised trial comparing combinations of cyclophosphamide and cisplatin without or with doxorubicin or 4′-epi-doxorubicin in the treatment of advanced ovarian cancer

✍ Z. Hernádi; B. Juhász; R. Póka; L.G. Lampé 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 563 KB

Re: Final results of sequential doxorubi

Re: Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium

✍ Christopher J. Logothetis; Arlene Siefker-Radtke 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Phase I trial of paclitaxel, carboplatin

Phase I trial of paclitaxel, carboplatin, and topotecan with or without filgrastim (granulocyte-colony stimulating factor) in the treatment of patients with advanced, refractory cancer

✍ John D. Hainsworth; Howard A. Burris III; Lisa H. Morrissey; F. Anthony Greco 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 3 views

## Background: Topotecan is a new antineoplastic agent with a broad spectrum of activity. the purpose of this phase i trial was to define the maximum tolerated dose of topotecan when added to the widely used combination of paclitaxel and carboplatin. ## Methods: Patients with advanced cancer that

Combination of cisplatin/S-1 in the trea

Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study

✍ Ajani, J.A.; Buyse, M.; Lichinitser, M.; Gorbunova, V.; Bodoky, G.; Douillard, J 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 502 KB

A phase 2 study of sequential neoadjuvan

A phase 2 study of sequential neoadjuvant chemotherapy with gemcitabine and doxorubicin followed by gemcitabine and cisplatin in patients with large or locally advanced operable breast cancer: results from long-term follow-up

✍ Julka, Pramod K.; Chacko, Raju T.; Nag, Shona; Parshad, Rajinder; Nair, Aravinda 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 244 KB

1081 PUBLICATION Preliminary report of p

1081 PUBLICATION Preliminary report of phase II study of neoadjuvant chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in locally advanced squamous cell carcinoma of the head and neck cancer (SCCHN) patients

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 275 KB